Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Accurate diagnosis and new therapies are crucial for effectively treating certain types of hair loss.

Extracellular vesicles could revolutionize skincare by improving skin repair and anti-aging, but face regulatory and cost challenges.

Antibiotics can reduce acne but may lead to resistant bacteria, and understanding the skin's bacteria is important for treatment.

Azithromycin and Roxithromycin can remove aging cells and may help with anti-aging.

New treatments for Dissecting cellulitis show promise, but more research is needed to understand the disease and establish a standard treatment plan.

New psoriasis treatments are effective but come with side effects and risks.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Pregnancy can trigger severe rosacea, which may be treated with antibiotics and steroids, but there's no clear treatment guideline.

Treating sheep and wild goats with specific medications and bathing sheep was 100% effective against a contagious skin disease caused by mites.

Diuretics can cause serious side effects and should be used carefully.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Topical immunomodulators are effective and safe for treating immune-related skin conditions.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Immunoadsorption successfully treated a man's resistant polymyositis.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Anti-CD19 therapy may help treat SLE and NMOSD.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.